Premium
Moleculin Biotech Inc (MBRX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute... Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.2199 | -8.49034749035 | 2.59 | 2.78 | 2.26 | 420697 | 2.5561265 | CS |
| 4 | 0.0101 | 0.427966101695 | 2.36 | 3.69 | 2.26 | 1237301 | 2.86432505 | CS |
| 12 | -0.0699 | -2.86475409836 | 2.44 | 3.69 | 2 | 543076 | 2.74516265 | CS |
| 26 | -1.6999 | -41.7665847666 | 4.07 | 5.3 | 1.79 | 336441 | 2.81975123 | CS |
| 52 | 1.9311 | 439.886104784 | 0.439 | 7.98 | 0.2625 | 2200651 | 0.80510748 | CS |
| 156 | 1.8001 | 315.807017544 | 0.57 | 7.98 | 0.25 | 1419628 | 1.03898401 | CS |
| 260 | -0.9799 | -29.2507462687 | 3.35 | 7.98 | 0.25 | 909201 | 1.08337475 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
